Amber Enterprises completes 30.2% equity stake acquisition in Ascent Circuits

Amber Enterprises India Limited has announced the successful completion of acquiring a 30.2% equity stake in Ascent Circuits Private Limited. This strategic acquisition, completed on 18 October 2026, involved the purchase of 1,500 equity stakes. The transaction was executed through a Share Swap Agreement, marking a significant step in the consolidation of ownership within the company.

Amber Enterprises Acquires Majority Stake in Ascent Circuits

Amber Enterprises India Limited has officially concluded its acquisition of a substantial 30.2% equity stake in Ascent Circuits Private Limited. This significant transaction was completed on 18 October 2026, following the execution of a Share Swap Agreement. The acquired stake comprises 1,500 equity shares, representing a key move towards consolidating ownership in the company.

Details of the Share Swap Agreement

The acquisition was facilitated through a Share Swap Agreement between IL&IN Electronics (India) Private Limited (the “Company”) and J. Amber S., for the acquisition of remaining equity stake in Ascent Circuits. The agreement involved the transfer of 1,500 equity stakes, underscoring the strategic importance of this consolidation for Amber Enterprises. Previously, on 18th October 2026, Amber Enterprises had announced the completion of this transaction.

Formal Notification and Previous Disclosure

This disclosure is made in accordance with Regulation 30(2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. The company had previously informed the stock exchanges regarding this transaction on 18th October 2026, detailing the acquisition of equity shares in Ascent Circuits. The announcement also notes that further details regarding the acquired company, IL&IN Electronics (India) Private Limited, are also available. The total number of shares of Ascent Circuits acquired by the company is 1,500.

Source: BSE

Previous Article

GlaxoSmithKline Pharmaceuticals reports Q2 2026 financial results

Next Article

Bayer CropScience declares interim dividend of Rs 90 per share